Completed Supportive Care and Symptom Management Grants
PI Name |
Organization - Company | Title | Major Program / Research Group | FOA |
|---|---|---|---|---|
| CHERRIER, MONIQUE | UNIVERSITY OF WASHINGTON | Assessment of Cognitive &Mood Effects from ADT in Men with Prostate Cancer | Cognitive Dysfunction | |
| Cole, Peter D | Albert Einstein College Of Medicine, Inc | Markers of Cognitive Decline During Treatment for Childhood ALL | Community Oncology and Prevention Trials, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction | |
| Cole, Peter D | Rbhs -Cancer Institute Of New Jersey | Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats | Community Oncology and Prevention Trials, Cognitive Dysfunction | PA-11-260 |
| JACOBSEN, PAUL B | H. LEE MOFFITT CANCER CTR &RES INST | LHRH Agonist Therapy and Cognitive Functioning in Men with Prostate Cancer | Cognitive Dysfunction | PA-07-070 |
| Janelsins, Michelle C | University Of Rochester | Interventions for Cognitive Impairment in Colorectal Cancer Patients | Community Oncology and Prevention Trials, Cognitive Dysfunction | |
| Janelsins, Michelle C | University Of Rochester | Clinical and Translational Approaches to Cognitive Impairments in Cancer | Community Oncology and Prevention Trials, Cognitive Dysfunction | RFA-RM-13-007 |
| Kai, Mihoko | Johns Hopkins University | Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell | Community Oncology and Prevention Trials, Cognitive Dysfunction | PAR-15-340 |
| Orchard, Tonya S | Ohio State University | Effect of n-3 fatty acids and sugars on chemotherapy-induced cognitive deficits | Community Oncology and Prevention Trials, Cognitive Dysfunction | PA-13-302 |
| WALKER, ELLEN ANN | TEMPLE UNIV OF THE COMMONWEALTH | Effects of chemotherapeutic agents on learning and memory in mice | Cognitive Dysfunction | PA-07-070 |
| WU, LISA MARIA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Qualitative analysis of cognitive functioning of prostate cancer survivors on ADT | Community Oncology and Prevention Trials, Cognitive Dysfunction | PAR-09-003 |